How important is the pathological margin distance in vulvar cancer?
Introduction
Vulvar cancer accounts for approximately 3%–5% of all gynecological malignancies.1 It usually affects women with a median age of 65–70 years,1, 2 and most cases are squamous cell carcinoma.1, 2 Surgery is the cornerstone treatment for vulvar cancer, and its prognosis is linked to inguinal lymph node (LN) metastasis.1, 2, 3, 4 The current management of vulvar cancer depends on the extent of disease and includes primary tumor resection with a safety margin and inguinofemoral LN staging.2, 4, 5 If LN metastasis is observed, the standard postoperative therapy is inguinal and pelvic radiotherapy.5 For patients who have unifocal disease, tumors up to 4 cm, and clinically negative groins, the sentinel node procedure should be offered. In cases with positive sentinel nodes, a complete inguinofemoral lymphadenectomy should be performed.2
Due to the low incidence of vulvar cancer, there are few evaluable randomized trials, and controversies remain regarding the best treatment approach. The ideal surgical margin is still debated—the current consensus is that final pathological margin should be at least 8 mm, which might correspond to intended surgical margins of 1–2 cm.2 This concept may drive to mutilation or neoadjuvant radiotherapy, especially in tumors that lie close to the clitoris, urethra, or anus. Thus, our aim was to determine the value of pathological free margin distance with regard to local recurrence (LR) in a retrospective series of patients with vulvar squamous cell carcinoma (VSCC) who were treated at our institution.
Section snippets
Methods
We analyzed a series of 205 patients who were treated for VSCC from April 1980 to October 2013 at AC Camargo Cancer Center. We excluded patients who received neoadjuvant treatment. Twelve (5.8%) patients received wide local resection, and the remaining subjects underwent radical vulvectomies. Because our primary objective was to correlate pathological free margin with LR, we included 37 (18%) patients who did not undergo inguinal lymphadenectomy for medical reasons and stage IA. Ten (4.9%)
Clinical and pathological characteristics
Clinical and pathological characteristics are listed in Table 1. The median age was 69 years (range: 28–91). The median tumor size was 4.2 cm (range: 0.3–18), and the median depth of invasion was 8.5 mm (range: 0.1–32). The median PFM distance was 10 mm (range: 1–65). Of 119 patients with lymphovascular invasion with evaluable data, 25 (21%) were positive. Of 118 patients with perineural invasion with evaluable data, 25 (21.2%) were positive. A total of 99 (63.1%), 43 (27.4%), and 15 (9.6%)
Discussion
In this study, we determined the effects of pathological surgical margin distance and other prognostic factors on local recurrence in 205 patients. Our data suggest no correlation between pathological margin distance and the risk of LR, in contrast to previous series.7, 8, 9
Even after the introduction of triple incision surgery, radical vulvectomy and the removal of all external genitalia remained the standard treatment for VSCC—until the development of radical local excision. No randomized
Conflict of interest statement
The authors declare no conflict of interest.
References (20)
- et al.
Surgery and radiotherapy in vulvar cancer
Crit Rev Oncol Hematol
(2006) - et al.
Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study)
Am J Obstet
(1991) - et al.
Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system
Eur J Surg Oncol
(2013) - et al.
Clinical management of primary vulvar cancer
Eur J Cancer
(2011) - et al.
Surgical–pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
Gynecol Oncol
(1990) - et al.
Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis
Gynecol Oncol
(2007) - et al.
An alternate approach to early cancer of the vulva
Am J Obstet Gynecol
(1979) - et al.
Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy
Gynecol Oncol
(1995) - et al.
Invasive vulvar carcinoma and the question of the surgical margin
Int J Gynaecol Obstet
(2011) - et al.
Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins
Gynecol Oncol
(2013)
Cited by (35)
Prognostic role of perineural invasion in vulvar squamous cell carcinoma: A systematic review and meta-analysis
2022, European Journal of Surgical OncologyCitation Excerpt :To date, only the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG) have recommended to add the PNI assessment in routinely histopathological report of VSCC, even though its presence does not imply a more aggressive adjuvant treatment [39]. Several Authors have also described the association between PNI and the well-known aggressive pathological tumoral features: presence of lichen sclerosus, large tumor size, depth of invasion, stage III/IV disease, lymphatic vascular space invasion (LVSI), and intra- or extra-nodal spread [25–30]. No significant association to age, race/ethnicity, smoking history, histologic subtype, or grade have been described.
A review of prognostic factors in squamous cell carcinoma of the vulva: Evidence from the last decade
2021, Seminars in Diagnostic PathologyCitation Excerpt :Even though 2 cm is the cut-off in formal staging systems, a greater number of studies (12 studies) used 4 cm as a cut-off value. In these studies, tumor size was prognostic for PFS (6 of 7 univariate analyses, 2 of 6 multivariate analyses) and OS (4 of 9 univariate analyses, 1 multivariate analyses).10,40–42,45,47,52,57,60,64,65,74 In 3 studies assessing tumor size as a continuous variable, only 1 study found tumor size was prognostic for both PFS and OS in the multivariate analysis.41,56,67
Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group
2020, Journal of Gynecology Obstetrics and Human ReproductionA review of prognostic factors in squamous cell carcinoma of the vulva: Evidence from the last decade
2020, Seminars in Diagnostic PathologyCitation Excerpt :Amongst 13 studies, 8 univariate analyses [15,40,43,59,65,66] found LVSI to be prognostic for OS, but this was not supported by any multivariate analyses. 13 analyses (8 univariate [9,15,19,39,41,45,68], 4 multivariate [40,65,66] and 1 method not specified [10] ) did not find a statistically significant relationship between LVSI and OS. The studies did not distinguish between focal or extensive LVSI.
Multivariate analysis of prognostic factors in primary squamous cell vulvar cancer: The role of perineural invasion in recurrence and survival
2019, European Journal of Surgical OncologyCitation Excerpt :Data in the literature regarding the role of PNI in vulvar cancer is lacking [9], although our findings confirm the most recent growing body of evidence [6]. Papers reviewing the presence of PNI are few and scanty, in fact, in literature, the prevalence rate of this pathological feature in VSCC ranges from 7.6% to 52% [5,6]. In our study, there are consecutive cases of VSCC and systematic evaluation of PNI brought to a prevalence rate of 31.1%, which is a not negligible quote of patients.
Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group
2019, European Journal of Surgical Oncology